Involvement of fatty acid-CoA ligase 4 in hepatocellular carcinoma growth: Roles of cyclic AMP and p38 mitogen-activated protein kinase

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 17

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

348

HTML

2903

Figures (1-5)

274

Sum=3525

May 7, 2005 (publication date) through Nov 23, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. May 7, 2005; 11(17): 2557-2563
Published online May 7, 2005. doi: 10.3748/wjg.v11.i17.2557

Full Size Figure Download Figure

Figure 4 Effect of p38 inhibitor on the expression of FACL4 in Hep3B cells. ^aP<0.05 vs control.

Citation: Liang YC, Wu CH, Chu JS, Wang CK, Hung LF, Wang YJ, Ho YS, Chang JG, Lin SY. Involvement of fatty acid-CoA ligase 4 in hepatocellular carcinoma growth: Roles of cyclic AMP and p38 mitogen-activated protein kinase. World J Gastroenterol 2005; 11(17): 2557-2563
URL: https://www.wjgnet.com/1007-9327/full/v11/i17/2557.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i17.2557